These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 19121347)

  • 1. Lipid extrudates as novel sustained release systems for pharmaceutical proteins.
    Schulze S; Winter G
    J Control Release; 2009 Mar; 134(3):177-85. PubMed ID: 19121347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New insight into the role of polyethylene glycol acting as protein release modifier in lipidic implants.
    Herrmann S; Mohl S; Siepmann F; Siepmann J; Winter G
    Pharm Res; 2007 Aug; 24(8):1527-37. PubMed ID: 17380261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms controlling protein release from lipidic implants: effects of PEG addition.
    Herrmann S; Winter G; Mohl S; Siepmann F; Siepmann J
    J Control Release; 2007 Apr; 118(2):161-8. PubMed ID: 17275943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Continuous release of Rh-interferon (alpha-2a from triglyceride implants: storage stability of the dosage forms.
    Mohl S; Winter G
    Pharm Dev Technol; 2006 Feb; 11(1):103-10. PubMed ID: 16544914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controlled release minocycline-lipid-complex extrudates for the therapy of periodontitis with enhanced flexibility.
    Kirchberg M; Eick S; Buchholz M; Rosche F; Kiesow A; Sarembe S; Mäder K
    Int J Pharm; 2020 Aug; 586():119578. PubMed ID: 32615242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous release of rh-interferon alpha-2a from triglyceride matrices.
    Mohl S; Winter G
    J Control Release; 2004 May; 97(1):67-78. PubMed ID: 15147805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic studies on the release of lysozyme from twin-screw extruded lipid implants.
    Sax G; Winter G
    J Control Release; 2012 Oct; 163(2):187-94. PubMed ID: 22964391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solid lipid extrudates as sustained-release matrices: the effect of surface structure on drug release properties.
    Reitz C; Strachan C; Kleinebudde P
    Eur J Pharm Sci; 2008 Nov; 35(4):335-43. PubMed ID: 18765281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug release from extruded solid lipid matrices: theoretical predictions and independent experiments.
    Güres S; Siepmann F; Siepmann J; Kleinebudde P
    Eur J Pharm Biopharm; 2012 Jan; 80(1):122-9. PubMed ID: 22008146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term release and stability of pharmaceutical proteins delivered from solid lipid implants.
    Vollrath M; Engert J; Winter G
    Eur J Pharm Biopharm; 2017 Aug; 117():244-255. PubMed ID: 28442372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Release pathways of interferon α2a molecules from lipid twin screw extrudates revealed by single molecule fluorescence microscopy.
    Sax G; Feil F; Schulze S; Jung C; Bräuchle C; Winter G
    J Control Release; 2012 Sep; 162(2):295-302. PubMed ID: 22820452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissolution from solid lipid extrudates containing release modifiers.
    Güres S; Kleinebudde P
    Int J Pharm; 2011 Jun; 412(1-2):77-84. PubMed ID: 21515350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eudragit RS 100 microparticles containing 2-hydroxypropyl-beta-cyclodextrin and glutathione: physicochemical characterization, drug release and transport studies.
    Trapani A; Laquintana V; Denora N; Lopedota A; Cutrignelli A; Franco M; Trapani G; Liso G
    Eur J Pharm Sci; 2007 Jan; 30(1):64-74. PubMed ID: 17118631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid lipid extrusion of sustained release dosage forms.
    Reitz C; Kleinebudde P
    Eur J Pharm Biopharm; 2007 Sep; 67(2):440-8. PubMed ID: 17481868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New investigation of distribution imaging and content uniformity of very low dose drugs using hot-melt extrusion method.
    Park JB; Kang CY; Kang WS; Choi HG; Han HK; Lee BJ
    Int J Pharm; 2013 Dec; 458(2):245-53. PubMed ID: 24157343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tailor-made dissolution profiles by extruded matrices based on lipid polyethylene glycol mixtures.
    Windbergs M; Strachan CJ; Kleinebudde P
    J Control Release; 2009 Aug; 137(3):211-6. PubMed ID: 19358867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New insights into process understanding of solid lipid extrusion (SLE) of extruded lipid implants for sustained protein delivery.
    Vollrath M; Engert J; Winter G
    Eur J Pharm Biopharm; 2018 Sep; 130():11-21. PubMed ID: 29913270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel mathematical model quantifying drug release from lipid implants.
    Siepmann F; Herrmann S; Winter G; Siepmann J
    J Control Release; 2008 Jun; 128(3):233-40. PubMed ID: 18442866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-step solid lipid extrusion as a process to modify dissolution behavior.
    Windbergs M; Gueres S; Strachan CJ; Kleinebudde P
    AAPS PharmSciTech; 2010 Mar; 11(1):2-8. PubMed ID: 20309654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NIR spectroscopy-a non-destructive analytical tool for protein quantification within lipid implants.
    Schönbrodt T; Mohl S; Winter G; Reich G
    J Control Release; 2006 Aug; 114(2):261-7. PubMed ID: 16872710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.